Hammerhead-type FXR agonists induce an enhancer RNA Fincor that ameliorates nonalcoholic steatohepatitis in mice

  1. Jinjing Chen
  2. Ruoyu Wang
  3. Feng Xiong
  4. Hao Sun
  5. Byron Kemper
  6. Wenbo Li  Is a corresponding author
  7. Jongsook Kemper  Is a corresponding author
  1. Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, United States
  2. Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center, United States
8 figures and 6 additional files

Figures

Figure 1 with 2 supplements
Activation of farnesoid X receptor (FXR) by GW4064 induces FXR-induced non-coding RNA (Fincor), a novel enhancer RNA (eRNA), in mouse liver.

(A) Volcano plot from RNA-seq showing significantly induced eRNAs (Fincor is highlighted) in the livers of C57BL/6 male mice treated with GW4064 (i.p. injection, 30 mg/kg, 1 hr) or vehicle. The x …

Figure 1—figure supplement 1
Examples of FXR-regulated eRNAs and time course expression of Fincor after FXR activation.

(A, B) Examples of farnesoid X receptor (FXR)-regulated eRNAs produced near the genes Hes1 (A) and Slc35g1 (B) were shown. (C) Time course expression of FXR-induced non-coding RNA (Fincor). C57BL/6 …

Figure 1—figure supplement 2
RNA-seq analysis of the differentially expressed genes in the GW4064-treated mouse liver.

(A) Volcano plot showing the differential expressed genes (DEGs) after GW4064 treatment (DESeq2 FDR <0.05). The numbers refer to the number of genes up- or downregulated. (B) Bar plot showing the …

Figure 2 with 1 supplement
Ligand-activated farnesoid X receptor (FXR) directly activates transcription of enhancer RNAs including FXR-induced non-coding RNA (Fincor) in the liver.

(A) Left: experimental outline. Fxr floxed (Fxr-Flox) and Fxr liver-specific knockout (Fxr-LKO) male mice were fasted overnight and treated with vehicle or GW4064, and livers were collected 1 hr …

Figure 2—figure supplement 1
Validation of Fincor expression and the analysis of the epigenetic features (presence of histone marks and binding of FXR and RXR⍺) at the enhancers that display FXR-induced eRNAs.

(A) Farnesoid X receptor (FXR) protein levels in the livers isolated from Fxr floxed (Fxr-Flox) and Fxr liver-specific knockout (Fxr-LKO) mice are shown. (B) Validation of hepatic FXR-dependent …

Farnesoid X receptor-induced non-coding RNA (Fincor) is a liver-specific nucleus-enriched eRNA.

(A) Expression levels of Fincor in various tissues after GW4064 treatment. Data from C57BL/6 male mice fasted overnight and i.p. injected with vehicle or GW4064 (30 mg/kg) for 1 hr (n=2/group). Data …

Figure 3—source data 1

Original file for the gel images shown in Figure 3C.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig3-data1-v1.zip
Figure 3—source data 2

Original file for the gel images shown in Figure 3C with highlighted bands and sample labels.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig3-data2-v1.zip
Figure 3—source data 3

Original file for the immunoblot image shown in Figure 3F.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig3-data3-v1.zip
Figure 3—source data 4

Original file for the immunoblot image shown in Figure 3F with highlighted bands and sample labels.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig3-data4-v1.zip
Farnesoid X receptor-induced non-coding RNA (Fincor) is induced by the hammerhead class of non-steroidal farnesoid X receptor (FXR) agonists, including GW4064 and tropifexor.

(A) The chemical structures of the FXR agonists including the hammerhead class of synthetic FXR agonists, non-hammerhead-type synthetic agonist, semi-synthetic BA, and natural BA. BA: bile acid. (B) …

Figure 5 with 1 supplement
Generation of CRISPR/Cas9-mediated farnesoid X receptor-induced non-coding RNA (Fincor) liver-specific knockdown mice.

(A) Experimental scheme: male Cas9 mice were infected with adenovirus expressing sgRNA for Fincor or a control for 1 week. Then the liver and serum were collected from these mice after 4–5 hr of …

Figure 5—figure supplement 1
Generation of farnesoid X receptor-induced non-coding RNA (Fincor) liver-specific knockdown mice by CRISPR-Cas9 method.

(A) Left: experimental scheme for the farnesoid X receptor-induced non-coding RNA (Fincor) loss-of-function experiments. Right: illustration demonstrating the sequence targeted by the sgRNA in …

Figure 5—figure supplement 1—source data 1

Original file for the gel image shown in Figure 5—figure supplement 1.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig5-figsupp1-data1-v1.zip
Figure 5—figure supplement 1—source data 2

Original file for the gel image shown in Figure 5—figure supplement 1 with highlighted bands and sample labels.

https://cdn.elifesciences.org/articles/91438/elife-91438-fig5-figsupp1-data2-v1.zip
In diet-induced nonalcoholic steatohepatitis (NASH) mice, tropifexor-mediated beneficial effects on reducing hepatic steatosis are largely independent of farnesoid X receptor-induced non-coding RNA (Fincor).

(A–E) Male Cas9 mice were fed a NASH diet for 12 weeks. The mice were randomly assigned to three groups and infected with adenovirus expressing sgRNA for Fincor or control. Three days later, the …

Figure 7 with 1 supplement
In diet-induced nonalcoholic steatohepatitis (NASH) mice, tropifexor-mediated beneficial effects on reducing liver fibrosis and inflammation are diminished by farnesoid X receptor-induced non-coding RNA (Fincor) downregulation.

(A) Representative images from hematoxylin and eosin (H&E), TUNEL, Sirius Red, and F4/80 staining of liver sections from the same cohort of mice described in Figure 6. Scale bar (50 μm). Image …

Figure 7—figure supplement 1
The effects of farnesoid X receptor-induced non-coding RNA (Fincor) downregulation on nonalcoholic steatohepatitis (NASH) pathologies.

Male Cas9 mice were fed with a NASH diet for 12 weeks. Then these mice were randomly assigned to two groups and infected with adenovirus expressing sgRNA for Fincor or control. The tissues were …

Hepatic expression of farnesoid X receptor-induced non-coding RNA (Fincor) is elevated in liver disease associated with inflammation and fibrosis.

(A) C57BL/6 mice were fed with a high-fat diet for 12 weeks. The liver RNAs were extracted and Fincor expression was measured (n=5/group). (B) C57BL/6 mice were fed with a high-fat diet with high …

Additional files

Supplementary file 1

Sequencing data generated in this study and a list of Farnesoid X receptor (FXR)-associated eRNAs.

https://cdn.elifesciences.org/articles/91438/elife-91438-supp1-v1.xlsx
Supplementary file 2

Differentially expressed genes in the FXR-induced non-coding RNA (Fincor)-downregulated mice liver.

https://cdn.elifesciences.org/articles/91438/elife-91438-supp2-v1.xlsx
Supplementary file 3

The binding of transcription factors at the FXR-induced non-coding RNA (Fincor) locus.

https://cdn.elifesciences.org/articles/91438/elife-91438-supp3-v1.docx
Supplementary file 4

Predicted RNA binding proteins (RBPs) binding to FXR-induced non-coding RNA (Fincor).

https://cdn.elifesciences.org/articles/91438/elife-91438-supp4-v1.docx
Supplementary file 5

Primer sequences used in this study.

https://cdn.elifesciences.org/articles/91438/elife-91438-supp5-v1.docx
MDAR checklist
https://cdn.elifesciences.org/articles/91438/elife-91438-mdarchecklist1-v1.docx

Download links